BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34997020)

  • 21. Paired comparisons of mutational profiles before and after brachytherapy in asian uveal melanoma patients.
    Lee WS; Lee J; Choi JJ; Kang HG; Lee SC; Kim JH
    Sci Rep; 2021 Sep; 11(1):18594. PubMed ID: 34545149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined mutation and copy-number variation detection by targeted next-generation sequencing in uveal melanoma.
    Smit KN; van Poppelen NM; Vaarwater J; Verdijk R; van Marion R; Kalirai H; Coupland SE; Thornton S; Farquhar N; Dubbink HJ; Paridaens D; de Klein A; Kiliç E
    Mod Pathol; 2018 May; 31(5):763-771. PubMed ID: 29327717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BAP1 germline mutation in two first grade family members with uveal melanoma.
    Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H
    Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastatic disease in uveal melanoma: importance of a genetic profile?
    Van Beek JG; Koopmans AE; Vaarwater J; Verdijk RM; de Klein A; Naus NC; Kiliç E
    Melanoma Res; 2015 Oct; 25(5):447-9. PubMed ID: 26086698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastatic Disease in Polyploid Uveal Melanoma Patients Is Associated With BAP1 Mutations.
    Yavuzyigitoglu S; Mensink HW; Smit KN; Vaarwater J; Verdijk RM; Beverloo B; Brüggenwirth HT; van Marion R; Dubbink HJ; Paridaens D; Naus NC; de Klein A; Kiliç E;
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):2232-9. PubMed ID: 27116551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transposase mapping identifies the genomic targets of BAP1 in uveal melanoma.
    Yen M; Qi Z; Chen X; Cooper JA; Mitra RD; Onken MD
    BMC Med Genomics; 2018 Nov; 11(1):97. PubMed ID: 30400891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromosomal rearrangements in uveal melanoma: Chromothripsis.
    van Poppelen NM; Yavuzyigitoglu S; Smit KN; Vaarwater J; Eussen B; Brands T; Paridaens D; Kiliç E; de Klein A
    Genes Chromosomes Cancer; 2018 Sep; 57(9):452-458. PubMed ID: 29726589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.
    Robertson AG; Shih J; Yau C; Gibb EA; Oba J; Mungall KL; Hess JM; Uzunangelov V; Walter V; Danilova L; Lichtenberg TM; Kucherlapati M; Kimes PK; Tang M; Penson A; Babur O; Akbani R; Bristow CA; Hoadley KA; Iype L; Chang MT; ; Cherniack AD; Benz C; Mills GB; Verhaak RGW; Griewank KG; Felau I; Zenklusen JC; Gershenwald JE; Schoenfield L; Lazar AJ; Abdel-Rahman MH; Roman-Roman S; Stern MH; Cebulla CM; Williams MD; Jager MJ; Coupland SE; Esmaeli B; Kandoth C; Woodman SE
    Cancer Cell; 2017 Aug; 32(2):204-220.e15. PubMed ID: 28810145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of somatic mutations and chromosomal aberrations in the prognosis of uveal melanoma in a Spanish patient cohort.
    Silva-Rodríguez P; Bande M; Fernández-Díaz D; Lago-Baameiro N; Pardo M; José Blanco-Teijeiro M; Domínguez F; Loidi L; Piñeiro A
    Acta Ophthalmol; 2021 Nov; 99(7):e1077-e1089. PubMed ID: 33421325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic, prognostic, and cell-signaling advances in uveal melanoma.
    Harbour JW
    Am Soc Clin Oncol Educ Book; 2013; ():388-91. PubMed ID: 23714557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SF3B1 mutations are associated with alternative splicing in uveal melanoma.
    Furney SJ; Pedersen M; Gentien D; Dumont AG; Rapinat A; Desjardins L; Turajlic S; Piperno-Neumann S; de la Grange P; Roman-Roman S; Stern MH; Marais R
    Cancer Discov; 2013 Oct; 3(10):1122-1129. PubMed ID: 23861464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EFS shows biallelic methylation in uveal melanoma with poor prognosis as well as tissue-specific methylation.
    Neumann LC; Weinhäusel A; Thomas S; Horsthemke B; Lohmann DR; Zeschnigk M
    BMC Cancer; 2011 Aug; 11():380. PubMed ID: 21871071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CTLA4 , PD-1 , PD-L1 , PD-L2 , TIM-3 , TIGIT , and LAG3 DNA Methylation Is Associated With BAP1 -Aberrancy, Transcriptional Activity, and Overall Survival in Uveal Melanoma.
    de Vos L; Carrillo Cano TM; Zarbl R; Klümper N; Ralser DJ; Franzen A; Herr E; Gabrielpillai J; Vogt TJ; Dietrich J; Strieth S; Landsberg J; Dietrich D
    J Immunother; 2022 Sep; 45(7):324-334. PubMed ID: 35862127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated differential DNA methylation and gene expression of formalin-fixed paraffin-embedded uveal melanoma specimens identifies genes associated with early metastasis and poor prognosis.
    Ness C; Katta K; Garred Ø; Kumar T; Olstad OK; Petrovski G; Moe MC; Noer A
    Exp Eye Res; 2021 Feb; 203():108426. PubMed ID: 33387485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SF3B1 and EIF1AX mutations occur in primary leptomeningeal melanocytic neoplasms; yet another similarity to uveal melanomas.
    Küsters-Vandevelde HV; Creytens D; van Engen-van Grunsven AC; Jeunink M; Winnepenninckx V; Groenen PJ; Küsters B; Wesseling P; Blokx WA; Prinsen CF
    Acta Neuropathol Commun; 2016 Jan; 4():5. PubMed ID: 26769193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BAP1 regulates cell cycle progression through E2F1 target genes and mediates transcriptional silencing via H2A monoubiquitination in uveal melanoma cells.
    Pan H; Jia R; Zhang L; Xu S; Wu Q; Song X; Zhang H; Ge S; Xu XL; Fan X
    Int J Biochem Cell Biol; 2015 Mar; 60():176-84. PubMed ID: 25582751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hereditary uveal melanoma: a report of a germline mutation in BAP1.
    Höiom V; Edsgärd D; Helgadottir H; Eriksson H; All-Ericsson C; Tuominen R; Ivanova I; Lundeberg J; Emanuelsson O; Hansson J
    Genes Chromosomes Cancer; 2013 Apr; 52(4):378-84. PubMed ID: 23341325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Punctuated evolution of canonical genomic aberrations in uveal melanoma.
    Field MG; Durante MA; Anbunathan H; Cai LZ; Decatur CL; Bowcock AM; Kurtenbach S; Harbour JW
    Nat Commun; 2018 Jan; 9(1):116. PubMed ID: 29317634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development.
    Figueiredo CR; Kalirai H; Sacco JJ; Azevedo RA; Duckworth A; Slupsky JR; Coulson JM; Coupland SE
    J Pathol; 2020 Apr; 250(4):420-439. PubMed ID: 31960425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma.
    Matatall KA; Agapova OA; Onken MD; Worley LA; Bowcock AM; Harbour JW
    BMC Cancer; 2013 Aug; 13():371. PubMed ID: 23915344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.